Trademark Search in Canada

CLÉO -35

View On IC.GC.CA

REGISTERED

on 6 Jun 2016

Last Applicant/ Owned by

ALTIUS HEALTHCARE INC.

31B - 665 Millway AvenueConcord

ONTARIO

L4K3T8

Serial Number

1715295 filed on 13^th Feb 2015

Registration Number

TMA940010 registered on 6^th Jun 2016

Registration expiry Date

6^th Jun 2031

Correspondent Address

ROBIC AGENCE PI S.E.C./ ROBIC IP AGENCY LP

630, boul. René-Lévesque Ouest20e étageMontréal

QUÉBEC

H3B1S6

CLÉO -35

Trademark usage description

pharmaceutical preparations for the treatment of acne and other hormonal disorders, namely polycystic ovarian syndrome (pcos), cushing syndrome, andro Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of acne and other hormonal disorders, namely Polycystic ovarian syndrome (PCOS), Cushing Syndrome, androgenic tumors, and hyperplasia of the adrenal glands.

Classification kind code

Mark Details

Serial Number

1715295

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 51 on 31^st May 2016	Allowance Notice Sent
Submitted for opposition 50 on 31^st May 2016	Allowed
Submitted for opposition 42 on 17^th Feb 2016	Advertised
Submitted for opposition 26 on 28^th Jan 2016	Approved
Submitted for opposition 27 on 8^th Dec 2015	Approval Notice Sent
Submitted for opposition 22 on 1^st Oct 2015	Search Recorded
Submitted for opposition 20 on 1^st Oct 2015	Examiner's First Report
Submitted for opposition 31 on 19^th Feb 2015	Formalized
Submitted for opposition 1 on 16^th Feb 2015	Created
Submitted for opposition 30 on 13^th Feb 2015	Filed

CLÉO -35

Classification Information

Class [005]Pharmaceutical preparations for the treatment of acne and other hormonal disorders, namely Polycystic ovarian syndrome (PCOS), Cushing Syndrome, androgenic tumors, and hyperplasia of the adrenal glands.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceutical preparations for the treatment of acne and other hormonal disorders, namely Polycystic ovarian syndrome (PCOS), Cushing Syndrome, androgenic tumors, and hyperplasia of the adrenal glands.